{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T20:25:12Z","timestamp":1792959912221,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","award":["T32 GM065086"],"award-info":[{"award-number":["T32 GM065086"]}],"id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["F31 HL162483"],"award-info":[{"award-number":["F31 HL162483"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["SABUSA19F0"],"award-info":[{"award-number":["SABUSA19F0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["R01 HL139876"],"award-info":[{"award-number":["R01 HL139876"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["R35 GM133552"],"award-info":[{"award-number":["R35 GM133552"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006537","name":"Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jbc.2023.105242","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T18:14:45Z","timestamp":1694283285000},"page":"105242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Elexacaftor\/VX-445\u2013mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics"],"prefix":"10.1016","volume":"299","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9854-2999","authenticated-orcid":false,"given":"Minsoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0572-330X","authenticated-orcid":false,"given":"Eli Fritz","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5039-8825","authenticated-orcid":false,"given":"Carleen Mae P.","family":"Sabusap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibek","family":"Timalsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong S.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Sorscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4363-6116","authenticated-orcid":false,"given":"Lars","family":"Plate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.105242_bib1","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3389\/fphar.2019.01662","article-title":"CFTR modulators: the changing face of cystic fibrosis in the Era of precision medicine","volume":"10","author":"Lopes-Pacheco","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105242_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2772657","article-title":"Identification of the cystic fibrosis gene : cloning and characterization of complementary DNA","volume":"245","author":"Rommens","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.105242_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1055\/s-0039-1694021","article-title":"Cystic fibrosis: pathophysiology of lung disease","volume":"40","author":"Bergeron","year":"2019","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.jbc.2023.105242_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00138-18","article-title":"Cystic fibrosis and pseudomonas aeruginosa: the host-microbe interface","volume":"32","author":"Malhotra","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jbc.2023.105242_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/0884533615591604","article-title":"Nutrition management of cystic fibrosis in the 21st Century","author":"Schindler","year":"2015","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.jbc.2023.105242_bib6","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2023.105242_bib7","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2023.105242_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2011-200393","article-title":"Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation","volume":"67","author":"Clancy","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.jbc.2023.105242_bib9","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.3390\/ijms21124524","article-title":"Full rescue of F508del-CFTR processing and function by CFTR modulators can Be achieved by removal of two regulatory regions","volume":"21","author":"Uliyakina","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2023.105242_bib10","doi-asserted-by":"crossref","first-page":"18843","DOI":"10.1073\/pnas.1105787108","article-title":"Correction of the F508del-CFTR protein processing defect in\u00a0vitro by the investigational drug VX-809","volume":"108","author":"Van Goor","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.105242_bib11","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1172\/JCI24898","article-title":"Small-molecule correctors of defective \u0394F508-CFTR cellular processing identified by high-throughput screening","volume":"115","author":"Pedemonte","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2023.105242_bib12","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jbc.2023.105242_bib13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1124\/mol.118.111799","article-title":"Correctors of the major cystic fibrosis mutant interact through membrane-spanning domains S","volume":"93","author":"Laselva","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105242_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/prot.25496","article-title":"Comprehensive mapping of cystic fibrosis mutations to CFTR protein identifies mutation clusters and molecular docking predicts corrector binding site","volume":"86","author":"Molinski","year":"2018","journal-title":"Proteins Struct. Funct. Bioinforma."},{"key":"10.1016\/j.jbc.2023.105242_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1124\/mol.117.108373","article-title":"Direct binding of the corrector VX-809 to human CFTR NBD1: evidence of an allosteric coupling between the binding site and the NBD1:CL4 interface s","volume":"92","author":"Hudson","year":"2017","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105242_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cell.2021.12.009","article-title":"Mechanism of CFTR correction by type I folding correctors","volume":"185","author":"Fiedorczuk","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105242_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.ade2216","article-title":"Molecular structures reveal synergistic rescue of \u0394508 CFTR by Trikafta modulators","volume":"378","author":"Fiedorczuk","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.105242_bib18","doi-asserted-by":"crossref","first-page":"e139983","DOI":"10.1172\/jci.insight.139983","article-title":"Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination","volume":"5","author":"Veit","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2023.105242_bib19","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nchembio.1253","article-title":"Mechanism-based corrector combination restores \u0394F508-CFTR folding and function","volume":"9","author":"Okiyoneda","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2020.04.017","article-title":"Testicular pain following initiation of elexacaftor\/tezacaftor\/ivacaftor in males with cystic fibrosis","author":"Rotolo","year":"2020","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jbc.2023.105242_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jcf.2021.10.002","article-title":"Mental status changes during elexacaftor\/tezacaftor\/ivacaftor therapy","volume":"21","author":"Heo","year":"2022","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jbc.2023.105242_bib22","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1242\/jcs.177907","article-title":"Correctors of mutant CFTR enhance subcortical cAMP-PKA signaling through modulating ezrin phosphorylation and cytoskeleton organization","volume":"129","author":"Abbattiscianni","year":"2016","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jbc.2023.105242_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-020-03540-9","article-title":"Dysregulated signalling pathways in innate immune cells with cystic fibrosis mutations","author":"Lara-Reyna","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jbc.2023.105242_bib24","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1159\/000475578","article-title":"Combination of correctors rescues CFTR transmembrane-domain mutants by mitigating their interactions with proteostasis","volume":"41","author":"Lopes-Pacheco","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jbc.2023.105242_bib25","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033928","article-title":"Chaperoning endoplasmic reticulum\u2013 associated degradation (ERAD) and protein conformational diseases","volume":"11","author":"Needham","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3390\/ijms21020452","article-title":"Regulation of CFTR biogenesis by the proteostatic network and pharmacological modulators","volume":"21","author":"Estabrooks","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2023.105242_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cell.2006.06.041","article-title":"Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator","volume":"126","author":"Younger","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105242_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/35050509","article-title":"The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation","volume":"3","author":"Meacham","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib29","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nature15729","article-title":"\u0394f508 CFTR interactome remodelling promotes rescue of cystic fibrosis","volume":"528","author":"Pankow","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105242_bib30","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.jmb.2018.06.017","article-title":"A\u00a0proteomic variant approach (ProVarA) for personalized medicine of inherited and somatic disease","volume":"430","author":"Hutt","year":"2018","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib31","doi-asserted-by":"crossref","first-page":"ar62","DOI":"10.1091\/mbc.E21-11-0578","article-title":"Distinct proteostasis states drive pharmacologic chaperone susceptibility for cystic fibrosis transmembrane conductance regulator misfolding mutants","volume":"33","author":"McDonald","year":"2022","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2023.105242_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100598","article-title":"The CFTR P67L variant reveals a key role for N-terminal lasso helices in channel folding, maturation, and pharmacologic rescue","volume":"296","author":"Sabusap","year":"2021","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105242_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/protein\/5.3.213","article-title":"The function of tryptophan residues in membrane proteins","volume":"5","author":"Schiffer","year":"1992","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.jbc.2023.105242_bib34","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1021\/bi000073v","article-title":"Analysis of the role of interfacial tryptophan residues in controlling the topology of membrane proteins","volume":"39","author":"Ridder","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.105242_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0092-8674(95)90240-6","article-title":"Degradation of CFTR by the ubiquitin-proteasome pathway","volume":"83","author":"Ward","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2023.105242_bib36","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121159","article-title":"Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators","volume":"3","author":"Han","year":"2018","journal-title":"JCI insight"},{"key":"10.1016\/j.jbc.2023.105242_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86581","article-title":"Analysis of cystic fibrosis\u2013associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases","volume":"1","author":"Sabusap","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2023.105242_bib38","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.RA120.002168","article-title":"Thyroglobulin interactome profiling defines altered proteostasis topology associated with thyroid dyshormonogenesis","volume":"20","author":"Wright","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.jbc.2023.105242_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008889","article-title":"Cystic fibrosis: some gating potentiators, including VX-770, diminish \u0394F508-CFTR functional expression","volume":"6","author":"Veit","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2023.105242_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2021.03.011","article-title":"Elexacaftor co-potentiates the activity of F508del and gating mutants of CFTR","author":"Veit","year":"2021","journal-title":"J.\u00a0Cyst. Fibros."},{"key":"10.1016\/j.jbc.2023.105242_bib41","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1038\/s41598-021-99184-1","article-title":"Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment","volume":"11","author":"Shaughnessy","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jbc.2023.105242_bib42","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/jpm11070643","article-title":"A\u00a0precision medicine approach to optimize modulator therapy for rare cftr folding mutants","volume":"11","author":"Veit","year":"2021","journal-title":"J.\u00a0Pers. Med."},{"key":"10.1016\/j.jbc.2023.105242_bib43","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.chembiol.2023.05.001","article-title":"General trends in the effects of VX-661 and VX-445 on the plasma membrane expression of clinical CFTR variants","volume":"30","author":"McKee","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib44","doi-asserted-by":"crossref","first-page":"848","DOI":"10.21037\/tcr.2019.05.05","article-title":"Knockdown of RPL34 suppresses osteosarcoma cell proliferation likely through EIF3\/FAU signaling pathway","volume":"8","author":"Huang","year":"2019","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.jbc.2023.105242_bib45","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1007\/s12010-022-03857-0","article-title":"Suppression of RPL34 inhibits tumor cell proliferation and promotes apoptosis in glioblastoma","volume":"194","author":"Du","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"10.1016\/j.jbc.2023.105242_bib46","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.4161\/cc.9.19.13299","article-title":"Depletion of ribosomal protein L37 occurs in response to DNA damage and activates p53 through the L11\/MDM2 pathway","volume":"9","author":"Llanos","year":"2010","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jbc.2023.105242_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068667","article-title":"Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network","volume":"8","author":"Daftuar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2023.105242_bib48","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/psp4.12751","article-title":"Translating in\u00a0vitro CFTR rescue into small molecule correctors for cystic fibrosis using the Library of Integrated Network-based Cellular Signatures drug discovery platform","volume":"11","author":"Strub","year":"2022","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jbc.2023.105242_bib49","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1172\/JCI124282","article-title":"Slowing ribosome velocity restores folding and function of mutant CFTR","volume":"129","author":"Oliver","year":"2019","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2023.105242_bib50","doi-asserted-by":"crossref","first-page":"21914","DOI":"10.1074\/jbc.M112.339788","article-title":"FK506 binding protein 8 peptidylprolyl isomerase activity manages a late stage of cystic fibrosis transmembrane conductance regulator (CFTR) folding and stability","volume":"287","author":"Hutt","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105242_bib51","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.molcel.2005.09.007","article-title":"Folding of CFTR is predominantly cotranslational","volume":"20","author":"Kleizen","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2023.105242_bib52","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.molcel.2011.02.027","article-title":"Ligand-driven vectorial folding of ribosome-bound human CFTR NBD1","volume":"41","author":"Khushoo","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.jbc.2023.105242_bib53","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1126\/science.aaa3974","article-title":"Translational tuning optimizes nascent protein folding in cells","volume":"348","author":"Kim","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.105242_bib54","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1038\/s41467-020-18101-8","article-title":"CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates","volume":"11","author":"Shishido","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.105242_bib55","doi-asserted-by":"crossref","first-page":"13477","DOI":"10.1074\/jbc.RA118.003192","article-title":"Correcting the F508del-CFTR variant by modulating eukaryotic translation initiation factor 3-mediated translation initiation","volume":"293","author":"Hutt","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105242_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1002462","article-title":"Ribosomal stalk protein silencing partially corrects the \u0394F508-CFTR functional expression defect","volume":"14","author":"Veit","year":"2016","journal-title":"PLoS Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib57","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.cub.2019.12.060","article-title":"Pre-emptive quality control of a misfolded membrane protein by ribosome-driven effects","volume":"30","author":"Lakshminarayan","year":"2020","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/jmcb\/mjv014","article-title":"Ribosomal proteins: functions beyond the ribosome","volume":"7","author":"Zhou","year":"2015","journal-title":"J.\u00a0Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib59","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/nature14427","article-title":"Structure of the human 80S ribosome","volume":"520","author":"Khatter","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.105242_bib60","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1096\/fj.07-105338","article-title":"Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia","volume":"22","author":"Sun","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.jbc.2023.105242_bib61","first-page":"1","article-title":"Hsp70 and DNAJA2 limit CFTR levels through degradation","volume":"14","author":"Chiaw","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2023.105242_bib62","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1091\/mbc.e04-04-0293","article-title":"The cochaperone HspBP1 inhibits the CHIP ubiquitin ligase and stimulates the maturation of the cystic fibrosis transmembrane conductance regulator","volume":"15","author":"Alberti","year":"2004","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.jbc.2023.105242_bib63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms23010024","article-title":"Rare trafficking cftr mutations involve distinct cellular retention machineries and require different rescuing strategies","volume":"23","author":"Ramalho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbc.2023.105242_bib64","doi-asserted-by":"crossref","first-page":"49320","DOI":"10.1074\/jbc.M108879200","article-title":"SERPINB12 is a novel member of the human ov-serpin family that is widely expressed and inhibits trypsin-like serine proteinases","volume":"276","author":"Askew","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105242_bib65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jmgm.2019.04.003","article-title":"Deciphering the three-domain architecture in schlafens and the structures and roles of human schlafen12 and serpinB12 in transcriptional regulation","volume":"90","author":"Chen","year":"2019","journal-title":"J.\u00a0Mol. Graph. Model."},{"key":"10.1016\/j.jbc.2023.105242_bib66","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1128\/MCB.20.14.4970-4978.2000","article-title":"Histone binding protein RbAp48 interacts with a complex of CREB binding protein and phosphorylated CREB","volume":"20","author":"Zhang","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib67","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nchembio.275","article-title":"Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis","volume":"6","author":"Hutt","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2023.105242_bib68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3390\/genes6030543","article-title":"Chromatin dynamics in the regulation of CFTR expression","volume":"6","author":"Gosalia","year":"2015","journal-title":"Genes (Basel)."},{"key":"10.1016\/j.jbc.2023.105242_bib69","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.devcel.2018.02.001","article-title":"Chaperone-independent peripheral quality control of CFTR by RFFL E3 ligase","volume":"44","author":"Okiyoneda","year":"2018","journal-title":"Dev. Cell"},{"key":"10.1016\/j.jbc.2023.105242_bib70","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA118.002607","article-title":"Silencing of the Hsp70-specific nucleotide-exchange factor BAG3 corrects the F508del-CFTR variant by restoring autophagy","volume":"293","author":"Hutt","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105242_bib71","doi-asserted-by":"crossref","first-page":"45920","DOI":"10.1074\/jbc.M204196200","article-title":"Ubiquitylation of BAG-1 suggests a novel regulatory mechanism during the sorting of chaperone substrates to the proteasome","volume":"277","author":"Alberti","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.105242_bib72","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1159\/000343303","article-title":"BAG-1 stabilizes mutant F508del-CFTR in a ubiquitin-like-domain-dependent manner","volume":"30","author":"Mendes","year":"2012","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.jbc.2023.105242_bib73","doi-asserted-by":"crossref","first-page":"5497046","DOI":"10.1155\/2020\/5497046","article-title":"Proteostasis failure in neurodegenerative diseases: focus on oxidative stress","volume":"2020","author":"H\u00f6hn","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.jbc.2023.105242_bib74","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1039\/b401644k","article-title":"Transfection of cells with custom-made calcium phosphate nanoparticles coated with DNA","volume":"14","author":"Welzel","year":"2004","journal-title":"J.\u00a0Mater. Chem."},{"key":"10.1016\/j.jbc.2023.105242_bib75","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1038\/nprot.2016.140","article-title":"Deep interactome profiling of membrane proteins by co-interacting protein identification technology","volume":"11","author":"Pankow","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jbc.2023.105242_bib76","first-page":"38","article-title":"MudPIT: A powerful proteomics tool for discovery","volume":"2","author":"Schirmer","year":"2009","journal-title":"Discov. Med."},{"key":"10.1016\/j.jbc.2023.105242_bib77","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1021\/acsinfecdis.0c00500","article-title":"Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus nonstructural proteins identifies unique and shared host-cell dependencies","volume":"6","author":"Davies","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jbc.2023.105242_bib78","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nmeth.2557","article-title":"The CRAPome: a contaminant repository for affinity purification mass spectrometry data","volume":"10","author":"Mellacheruvu","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jbc.2023.105242_bib79","doi-asserted-by":"crossref","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2023.105242_bib80","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1073\/pnas.1815287115","article-title":"Molecular structure of the ATP-bound, phosphorylated human CFTR","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.105242_bib81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/pro.3235","article-title":"UCSF ChimeraX: meeting modern challenges in visualization and analysis","volume":"27","author":"Goddard","year":"2018","journal-title":"Protein Sci."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823022706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823022706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:55:21Z","timestamp":1777409721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823022706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":81,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0021925823022706"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105242","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.02.04.527134","asserted-by":"object"}]},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elexacaftor\/VX-445\u2013mediated CFTR interactome remodeling reveals differential correction driven by mutation-specific translational dynamics","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.105242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"105242"}}